Skip to main content

Fungal Infections of Implantation (Chromoblastomycosis, Mycetoma, Entomophthoramycosis, and Lacaziosis)

  • Chapter
  • First Online:
  • 1776 Accesses

Part of the book series: Infectious Disease ((ID))

Abstract

Implantation mycoses include a heterogeneous group of fungal diseases that develop at the site of transcutaneous trauma. They are also known as “subcutaneous mycoses,” but this term seems to be imprecise because some of implantation mycoses may also involve muscles, fascia, cartilage, and bones, beyond the skin and the subcutaneous tissues. These diseases are a frequent health problem in Latin American countries and other tropical and subtropical areas of the world. Although these infections rarely cause disseminated or invasive disease, they have an important impact on public health, may be difficult to control, and often recur.The implantation mycoses covered in this chapter include chromoblastomycoses, eumycetoma, lacaziosis, and entomophthoramycoses.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Errol Reiss H, Shadomy HJ, Lyon M. Mycoses of implantation: fundamental medical mycology. Hoboken: Wiley-Blackwell; 2012. 475p.

    Google Scholar 

  2. Queiroz-Telles F, Nucci M, Colombo AL, et al. Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment. Med Mycol. 2011;49:225–36.

    Article  PubMed  Google Scholar 

  3. Bayles MA. Chromomycosis. In: Hay RJ, Herausgeber, Baillière’s clinical tropical medicine and communicable diseases. Tropical fungal infections. London: WB Saunders; 1986. p. 45–70.

    Google Scholar 

  4. La Hoz RM Baddley JW. Subcutaneous fungal infections. Curr Infect Dis Rep. 2012; published online 19 July 2012.

    Google Scholar 

  5. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. 2005;53:931–51.

    Article  PubMed  Google Scholar 

  6. Pang KR, Wu JJ, Huang DB, Tyring SK. Subcutaneous fungal infections. Dermatol Ther. 2004;17:523–31.

    Article  PubMed  Google Scholar 

  7. Queiroz-Telles F, Mc Ginnis MR, Salkin I, Graybill JR. Subcutaneous mycoses. Infect Dis Clin North Am. 2003;17:59–85.

    Article  PubMed  Google Scholar 

  8. Garnica M, Nucci M, Queiroz-Telles F. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis. 2009;22:559–63.

    Article  PubMed  Google Scholar 

  9. Rippon JW. Chromoblastomycosis and related dermal infections caused by dematiaceous fungi. In: Rippon JW, editor. Medical mycology. The pathogenic fungi and the pathogenic actinomycetes. 2 edn. Philadelphia: WB Saunders; 1982. p. 249–76.

    Google Scholar 

  10. Esterre P, Andriantsimahavandy A, et al. Forty years of chromoblastomycosis in Madagascar: a review. Am J Trop Med Hyg. 1996;55:45–7.

    CAS  PubMed  Google Scholar 

  11. Silva JP, de Souza W, Rozental S. Chromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil). Mycopathologia. 1998;143:171–5.

    Article  PubMed  Google Scholar 

  12. Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001;44:1–7.

    Article  CAS  PubMed  Google Scholar 

  13. Queiroz-Telles F, Esterre P, Perez-Blanco M, et al. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009;47:3–15.

    Article  PubMed  Google Scholar 

  14. Rudolph M. Über die brasilianische “Figueira” Vorläufige Mitteilung. Archiev Schiffs und Tropen-Hyg. 1914;18:498–9.

    Google Scholar 

  15. Castro RM, Castro LGM. On the priority of description chromomycosis. Mykosen. 1987;30:397–403.

    Article  CAS  PubMed  Google Scholar 

  16. Esterre P, Queiroz-Telles F. Management of chromoblastomycosis: novel perspectives. Curr Opin Infect Dis. 2006;19:148–52.

    Article  PubMed  Google Scholar 

  17. Fader RC, McGinnis MR. Infections caused by dematiaceous fungi: chromoblastomycosis and phaeohyphomycosis. Infect Dis Clin North Am. 1988;2(4):925–38.

    CAS  PubMed  Google Scholar 

  18. Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev. 2010;23:884–928.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Borelli D. Acrotheca aquaspersa nova, new species agent of chromomycosis. Acta Cient Venez. 1972;23:193–6.

    CAS  PubMed  Google Scholar 

  20. Barba-Gomez JF, Mayorga J, McGinnis MR, Gonzalez-Mendoza A. Chromoblastomycosis caused by Exophiala spinifera. J Am Acad Dermatol. 1992;26:367–70.

    Article  CAS  PubMed  Google Scholar 

  21. de Hoog GS Attili-Angelis D Vicente VA Van Den Ende AH Queiroz-Telles F. Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol. 2004;42:405–16.

    Article  PubMed  Google Scholar 

  22. Najafzadeh MJ, Gueidan C, Badali H, van den Ende AH, Xi L, de Hoog GS. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. Med Mycol. 2009;47:17–25.

    Article  CAS  PubMed  Google Scholar 

  23. Matsumoto T, Matsuda T, McGinnis MR, Ajello L. Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses. 1993;36:145–55.

    Article  CAS  PubMed  Google Scholar 

  24. McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol. 1983;8:1–16.

    Article  CAS  PubMed  Google Scholar 

  25. de Hoog GS, Nishikaku AS, Fernandez-Zeppenfeldt G, et al. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol. 2007;58:219–34.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Al-Doory Y. Chromomycosis. In: Di Salvo, AF editor. Occupational mycoses. Philadelphia: Lea & Febiger; 1983. p. 95–121.

    Google Scholar 

  27. Vicente AP, Attili DA, Queiroz-Telles F, et al. Isolation of Herpotrichiellacious fungi from the environment. Braz J Microbiol. 2001;32:47–51.

    Article  Google Scholar 

  28. Queiroz-Telles F, Santos, DWCL. Chromoblastomycosis in the clinical practice. Curr Fungal Infect Rep. doi:10.1007/s12281-012-0116-8.

    Google Scholar 

  29. Minotto R, Bernardi CDV, Mallmann LF, Edelweiss MIA, Scroferneker ML. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul. J Am Acad Dermatol. 2001;44:585–92.

    Article  CAS  PubMed  Google Scholar 

  30. Perez-Blanco M, Hernández Valles R, Garcia-Humbria L, Yegres F. Chromoblastomycosis in children and adolescents in the endemic area of the falcon state, Venezuela. Med Mycol. 2006;44:467–71.

    Article  CAS  PubMed  Google Scholar 

  31. Tschen JA, Knox JM, McGavran MH, Duncan C. Chromomycosis. Association of fungal elements and wood splinters Arch Dermatol 1974;120:107–8.

    Article  Google Scholar 

  32. Gezuele E, Mackinnon JE, Conti-Diaz IA. The frequent isolation of Phialophora verrucosa and Phialophora pedrosoi from natural sources. Sabouraudia. 1972;10:266–73.

    Article  CAS  PubMed  Google Scholar 

  33. Tsuneto LT, Arce-Gomez B, Petzl-Erler ML, Queiroz-Telles F. HLA-A29 and genetic susceptibility to chromoblastomycosis. J Med Vet Mycol. 1989;27:181–5.

    Article  CAS  PubMed  Google Scholar 

  34. Castro Lima Santos D Pedroso e Silva Cde M Almeida SR. Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis. Microbes Infect. 2005;7:708–13.

    Article  Google Scholar 

  35. Palmeira VF, Kneipp LF, Alviano CS, dos Santos AL. Phospholipase and esterase production by clinical strains of Fonsecaea pedrosoi and their interactions with epithelial cells. Mycopathologia 2010;170:31–7.

    Article  CAS  PubMed  Google Scholar 

  36. Carrion AL. Chromoblastomycosis. Ann NY Acad Sci. 1950;50:1255–82.

    Article  CAS  PubMed  Google Scholar 

  37. Esterre P, Pecarrère JL, Raharisolo C, Huerre M. Squamous cell carcinoma arising from chromomycosis. Report of two cases. Ann Pathol. 1999;19(6):516–20.

    CAS  PubMed  Google Scholar 

  38. Jamil A, Lee YY, Thevarajah S. Invasive squamous cell carcinoma arising from chromoblastomycosis. Med Mycol. 2012 Jan;50(1):99–102.

    Article  PubMed  Google Scholar 

  39. Zaias N, Rebell G. A simple and accurate diagnostic method in chromoblastomycosis. Arch Dermatol. 1973;108:545–6.

    Article  CAS  PubMed  Google Scholar 

  40. Lee MW, Hsu S, Rosen T. Spores and mycelia in cutaneous chromomycosis. J Am Acad Dermatol. 1998;39:850–2.

    Article  CAS  PubMed  Google Scholar 

  41. Zaias N. Chromomycosis. J Cutan Pathol. 1978;5:155–64.

    Article  CAS  PubMed  Google Scholar 

  42. Restrepo A, Gonzalez A, Gomez I, Arango M, de Bedout C. Treatment of chromoblastomycosis with itraconazole. Ann N Y Acad Sci. 1988;544:504–16.

    Article  CAS  PubMed  Google Scholar 

  43. Queiroz-Telles F, Purim KS, Fillus JN, et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol. 1992;31:805–12.

    Article  CAS  PubMed  Google Scholar 

  44. Esterre P, Inzan CK, Rtasioharana M, et al. A multicenter trial of terbinafine in patients with chromoblastomycosis: effects on clinical and biological criteria. J Dermatolog Treat. 1998;9:529–34.

    Article  Google Scholar 

  45. Bonifaz A, Saul A, Paredes-Solis V, Araiza J, Fierro-Arias L. Treatment of chromoblastomycosis with terbinafine: experience with four cases. J Dermatolog Treat. 2005;16:47–51.

    Article  CAS  PubMed  Google Scholar 

  46. Gupta AK, Taborda PR, Sanzovo AD. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol. 2002;40:529–34.

    Article  CAS  PubMed  Google Scholar 

  47. Pradinaud R, Bolzinger T. Treatment of chromoblastomycosis. J Am Acad Dermatol. 1991;25:869–70.

    Article  CAS  PubMed  Google Scholar 

  48. Bolzinger T, Pradinaud R, Sainte-Marie D, Dupont B, Chwetzoff E. Traitement de quatre cas de chromomycose à Fonsecaea pedrosoi par l’association 5-fluorocytosine-itraconazole. Nouv Dermatol. 1991;10:462–6.

    Google Scholar 

  49. Antonello VS, Appel da Silva MC, Cambruzzi DA, Santos BR, Queiroz-Telles F. Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association. Rev Inst Med Trop São Paulo. 2010;52:329–31.

    Article  PubMed  Google Scholar 

  50. Queiroz-Telles F, Santos DW. Challenges in the therapy of chromoblastomycosis. Mycopathologia. 2013;175:477–88.

    Article  PubMed  Google Scholar 

  51. Hiruma M, Kawada A, Yoshida M, Kouya M. Hyperthermic treatment of chromomycosis with disposable chemical pocket warmers. Report of a successfully treated case, with a review of the literature. Mycopathologia. 1993;122(2):107–14.

    Article  CAS  PubMed  Google Scholar 

  52. Azevedo C de M, Marques SG, Resende MA, Gonçalves AG, Santos DV, da Silva RR, de Sousa Mda G, de Almeida SR. The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis. Mycoses. 2008;51(4):341–4.

    Article  Google Scholar 

  53. Calzavara-Pinton PG, Venturini M, Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B: Biol. 2005;78:1–6.

    Article  CAS  Google Scholar 

  54. Lyon JP, Azevedo CMPS, Moreira LM, Lima CG, Resende MA. Photodynamic antifungal therapy against chromoblastomycosis. Mycopathologia. 2011;172:293–7.

    Article  CAS  PubMed  Google Scholar 

  55. Souza MGT, Belda W Jr., Spina R, et al. Topical application of imiquimod as a treatment for chromoblastomycosis. Clin Infect Dis. 2014;58:1734–37.

    Article  Google Scholar 

  56. Negroni R, Tobon A, Bustamante B, et al. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo. 2005;47:9–346.

    Article  Google Scholar 

  57. Criado PR, Careta MF, Valente NY, Martins JE, Rivitti EA, Spina R, Belda W Jr. Extensive longstanding chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy. J Dermatolog Treat. 2011;22(3):167–74.

    Article  CAS  PubMed  Google Scholar 

  58. Cortez KJ, Roilides E, Queiroz-Telles F, et al. Infections caused by Scedosporium. Clin Microbiol Rev. 2008;157–97.

    Google Scholar 

  59. Gill J. Indian naval medical reports—quoted by Ghosh LM, et al., 1950. Madura foot (mycetoma). Indian Med. Gaz. 1842;85:288.

    Google Scholar 

  60. Godfrey J. Diseases of the foot not hitherto described. Lancet. 1846;i:593–4.

    Google Scholar 

  61. Carter HV. On mycetoma or the fungus disease of India including notes of recent cases and new observations of the structure, etc. of the entophytic growth. Trans Med Physiol Soc Bombay. 1861;7:206–21.

    Google Scholar 

  62. Pinoy E. Actinomycoses and mycetomas. Borntragen (Leipzig). 1913;11:929–938.

    Google Scholar 

  63. Mahgoub ES, Murray IG. Mycetoma. London: William Heinemann Medical Book; 1973.

    Google Scholar 

  64. Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 2004;4:566–74.

    Article  PubMed  Google Scholar 

  65. Wendy WJ, van de Sande, Maghoub ES, Fahal Ahmed H, et al. The mycetoma knowledge gap: identification of research priorities. PLoS Negl Trop Dis. 2014;8(3):e2667.

    Article  Google Scholar 

  66. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Mycetoma. Clin Dermatol. 2007;25(2):195–202.

    Article  PubMed  Google Scholar 

  67. Cordeiro F, Bruno C, Reis C. Mycetoma. Am J Trop Med Hyg. 2011;85(5):791.

    Article  PubMed Central  PubMed  Google Scholar 

  68. Lichon V, Khachemoune A. Mycetoma: a review. Ann J Clin Dermatol. 2006;7(5):315–21.

    Article  Google Scholar 

  69. Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis. 2007;20(2):146–51.

    Article  PubMed  Google Scholar 

  70. Green WO, Jr., Adams TE. Mycetoma in the United States; a review and report of seven additional cases. Am J Clin Pathol. 1964;42:75–91.

    PubMed  Google Scholar 

  71. McGinnis MR, Fader RC. Mycetoma: a contemporary concept. Infect Dis Clin North Am. 1988;2:939–54.

    CAS  PubMed  Google Scholar 

  72. Estrada R, Chávez-López G, Estrada-Chávez G, López-Martínez R, Welsh O. Eumycetoma. Clin Dermatol. 2012;30:389–96.

    Article  PubMed  Google Scholar 

  73. Maiti PK, Ray A, Bandyopadhyay S. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health. 2002;7(9):788–91.

    Article  CAS  PubMed  Google Scholar 

  74. Wendy WJ, van de Sande. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7(11):e2550.

    Article  Google Scholar 

  75. Horre R, Schumacher G, Marklein G, Stratmann H, Wardelmann E, Gilges S, De Hoog GS, Schaal KP. Mycetoma due to Pseudallescheria boydii and co-isolation of Nocardia abscessus in a patient injured in road accident. Med Mycol. 2002;40:525–7.

    Article  CAS  PubMed  Google Scholar 

  76. Wethered DB, Markey MA, Hay RJ, Mahgoub ES, Gumaa SA. Ultrastructural and immunogenic changes in the formation of mycetoma grains. J Med Vet Mycol. 1987;25:39–46.

    Article  CAS  PubMed  Google Scholar 

  77. Fahal AH, Sheik HE, Homeida MM, Arabi YE, Mahgoub ES. Ultrasonographic imaging of mycetoma. Br J Surg. 1997;84:1120–2.

    Article  CAS  PubMed  Google Scholar 

  78. Sharif HS, Clark DC, Aabed MY, Aideyan OA, Mattsson TA, Haddad MC, Ohman SO, Joshi RK, Hasan HA, Haleem A. Mycetoma: comparison of MR imaging with CT. Radiology 1991;178:865–70.

    Article  CAS  PubMed  Google Scholar 

  79. Ameen M, Arenas R. Emerging therapeutic regimes for the management of mycetomas. Expert Opin Pharmacother. 2008;9(12):2077–85.

    Article  CAS  PubMed  Google Scholar 

  80. Ameen M. Managing mycetomas. Trop Doct. 2009;39(2):66–8.

    Article  PubMed  Google Scholar 

  81. Fahal AH, Rahman IA, El-Hassan AM, Abdel ME, Rahman EI, et al. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg. 2011;105:127–32.

    Article  CAS  PubMed  Google Scholar 

  82. Lobo JO. Um caso de blastomicose produzido por uma espécie nova, encontrada em Recife. Rev Med Pernambuco. 1931;1:763–5.

    Google Scholar 

  83. Taborda PR, Taborda VA, McGinnis R. Lacazia loboi gen. nov., com. nov., the etiologic agent of lobomycosis. J Clin Microbiol. 1999:2031–3.

    Google Scholar 

  84. Brito AC, Quaresma JAS. Lacaziosis (Jorge Lobo’s disease): review and update. An Bras Dermatol. 2007;82(5):461–74.

    Article  Google Scholar 

  85. Symmers WS. A possible case of Lobo’s disease acquired in Europe from a bottle-nosed dolphin (Tursiops truncatus). Bull Soc Pathol Exot. 1983;77:777–84.

    Google Scholar 

  86. Cowen DF. Lobo’s disease in a bottlenose dolphin (Tursiops truncatus) from Matagorda Bay, Texas. J Wildl Dis. 1993;29:488–9.

    Article  Google Scholar 

  87. Lopes PCS, Paula GS, Both VF, Xavier M, Scaramello AC. First case of lobomycosis in a bottlenose dolphin from Southern Brazil. Mar Mamm Sci. 1993;9:329–31.

    Article  Google Scholar 

  88. Bermudez L, Van Bressem MF, Reyes-Jaimes O, et al. Lobomycosis in man and lobomycosis-like disease in bottlenose dolphin, Venezuela. Emerg Infect Dis. 2009;15(8):1301–3.

    Article  PubMed Central  PubMed  Google Scholar 

  89. Rotstein DS, Burdett LG, McLellan L, et al. Lobomycosis in offshore bottlenose dolphins (Tursiops truncatus), North Carolina. Emerg Infect Dis. 2009;15(4):588–90.

    Article  PubMed Central  PubMed  Google Scholar 

  90. Cáceres S, Rodriguez-Toro G. Lobomicosis de 35 años de evolución. Ver Soc Dermatol. 1991;1:43–5.

    Google Scholar 

  91. Miranda MFR, Bittencourt MJS, Costa VS, Brito AC. Transepidermal elimination of parasites in Jorge Lobo’s disease. An Bras Dermatol. 2010;85(1):39–43.

    Article  PubMed  Google Scholar 

  92. Paniz-Mondolfi AE, Jaimes OR, Jones LD. Lobomycosis in Venezuela. Int J Dermatol. 2007;46:180–5.

    Article  PubMed  Google Scholar 

  93. Bustamante B, Seas C, Salomon M, Bravo F. Lobomycosis successfully treated with Posaconazole. Am J Trop Med Hyg. 2013;88(6):1207–8.

    Article  PubMed Central  PubMed  Google Scholar 

  94. Paltauf AP. Mycosis mucorina. Virchow’s Archiv fur Pathologische Anatomie und Physiologie und fur klinische Medicin. 1885;102:543–64.

    Google Scholar 

  95. Kwon-Chung KJ, Bennett JE. Medical mycology. Philadelphia: Lea & Febiger; 1992. S. 3–34.

    Google Scholar 

  96. Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (Zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis. 2012;54(Suppl 1):8–15.

    Article  Google Scholar 

  97. Gugnani HC. A review of zygomycosis due to Basidiobolus ranarum. Eur J Epidemiol. 1999;15:923–9.

    Article  CAS  PubMed  Google Scholar 

  98. Gugnani HC. Entomophthoramycosis due to Conidiobolus. Eur J Epidemiol.1992;8:391–6.

    Article  CAS  PubMed  Google Scholar 

  99. Ribes JA, Venover-Sams CL, Baker DJ. Clinical microbiology reviews. Zygomycetes Hum Dis. 2000;13(2):236–301.

    CAS  Google Scholar 

  100. Ahmed AO, JARIE AL, Al-Mohsen I, Suliman AL, et al. Pediatric gastrointestinal basidiobolomycosis. Pediatr Infect Dis J. 2003;22:1007–13.

    Article  Google Scholar 

  101. Kamalam A, Thambia AS. Entomophthtorae basidiobolae successfully treated with KI. Mykoen. 1979;22:82–4.

    Article  CAS  Google Scholar 

  102. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomicosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.

    Article  PubMed  Google Scholar 

  103. Vuillecard E, Testa J, Ravisse P, et al. Treatment of three cases of entomophthoramycosis with itraconazole. Bull Soc Fr Mycol Med. 1987;74:403.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Flavio Queiroz-Telles .

Editor information

Editors and Affiliations

Suggested Reading

Suggested Reading

Mycoses of Implantation

Errol Reiss H, Shadomy HJ and Marshall Lyon III: Mycoses of implantation: Fundamental Medical Mycology, edited by John Wiley & Sons, Inc, 2012. Wiley-Blackwell, 475.

La Hoz RM and & Baddley JW. Subcutaneous Fungal Infections Curr Infect Dis Rep 2012; published on line 19 July 2012.

Queiroz-Telles F, Nucci M, Colombo AL, et al.: Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment Med Mycol 2011;49:225–236.

Chromoblastomycosis

McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983;8:1–16.

Queiroz-Telles F and Santos DW. Challenges in the therapy of chromoblastomycosis. Mycopathologia. 2013;175:477–88.

Mycetoma

Ahmed, A. O., W. van Leeuwen, A. Fahal, W. van de Sande, H. Verbrugh, and A. van Belkum. 2004. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect. Dis. 4:566–574.

Cortez KJ, Roilides E, Queiroz-Telles F et al. Infections caused by Scedosporium Clin Microbiol Rev 2008;157–197.

Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Mycetoma. Clin Dermatol. 2007;25(2):195–202.

Lacaziosis

Brito AC, Quaresma JAS. Lacaziosis (Jorge Lobo’s disease): review and update. An Bras Dermatol. 2007;82(5):461–74.

Taborda PR, Taborda VA, McGinnis R. Lacazia loboi gen. nov., com. nov., the etiologic agent of lobomycosis. J Clin Micrbiol. 1999;2031–3.

Entomphtoromycosis

Kwon-Chung KJ. Taxonomy of Fungi Causing Mucormycosis and Entomophthoramycosis (Zygomycosis) and Nomenclature of the Disease: Molecular Mycologic Perspectives. Clin Infect Dis. 2012 February 1; 54(Suppl 1): S8–S15.

Roden, M.M, Zaoutis, TE, Buchanan, Knudsen, TA, Sarkisova, T.A, Schaufele, R.L, Sein, M, Sein, T, Chiou C.C, Chu, J.H, Kontoyiannis, D.P, Walsh, T.J. Epidemiology and outcome of zygomicosis: a Review of 929 reported Cases. Clinical Infectious Disease. 2005. 41: 634–53.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Queiroz-Telles, F., Santos, D., Azevedo, C. (2015). Fungal Infections of Implantation (Chromoblastomycosis, Mycetoma, Entomophthoramycosis, and Lacaziosis). In: Hospenthal, D., Rinaldi, M. (eds) Diagnosis and Treatment of Fungal Infections. Infectious Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-13090-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13090-3_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13089-7

  • Online ISBN: 978-3-319-13090-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics